![](https://ml.globenewswire.com/media/51670c91-d369-4a8c-8102-d393de9f6d19/small/download-jpg.jpg)
Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman
SAN FRANCISCO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Hagens Berman encourages Outset Medical (NASDAQ: OM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to …